Skip to content
Search

Latest Stories

E. coli (STEC) outbreak: Tips to reduce your risk of gastrointestinal infections

E. coli (STEC) outbreak: Tips to reduce your risk of gastrointestinal infections

Between 25 May and 4 June, 113 cases of E. coli (STEC) have been confirmed in the UK, with most cases occurring in England.

The UK Health Security Agency (UKHSA) has warned about a recent increase in cases of Shiga toxin-producing E. coli (STEC) in the UK.


As of 4 June, there have been 113 confirmed cases of the STEC O145 strain reported since 25 May 2024. These include 81 cases in England, 18 in Wales, 13 in Scotland, and 1 in Northern Ireland, with evidence suggesting that the latter case likely contracted during a visit to England.

While cases range from 2 to 79 years of age, the majority are found in young adults. Among the 81 cases identified in England so far, 61 per cent have been hospitalized.

However, the number of confirmed cases linked to this outbreak is expected to increase as additional samples undergo whole genome sequencing. The UKHSA notes that, typically, around 1,500 cases of STEC are reported annually.

According to the UKHSA, infections caused by STEC bacteria can cause severe bloody diarrhoea and, in some cases, more serious complications.

It is typically transmitted through consuming contaminated food but can also spread via close contact with an infected person, or through direct contact with an infected animal or its environment.

Causes of the present E. coli (STEC) outbreak

The agency is working with public health agencies in Scotland, Northern Ireland, and Wales to investigate the recent outbreak.

Whole genome sequencing of samples in the current investigation reveals that most cases are part of a single outbreak.

Given the wide geographic distribution of cases, the agency believes that this outbreak is most likely linked to a nationally distributed food item or multiple food items.

The source of the outbreak has not yet been confirmed, but there is currently no evidence linking it to open farms, drinking water, or swimming in contaminated seawater, lakes, or rivers.

Public health agencies are collaborating with the Food Standards Agency (FSA) and Food Standards Scotland to further investigate the source.

How to reduce the risk of E. coli infections

Trish Mannes, Incident Director at UKHSA, has shared some steps to help reduce the risk of E. coli infections and prevent their spread to others. These include:

  • Regular washing hands with warm water and soap
  • Use disinfectants to clean surfaces to stop infections from spreading
  • Adhere to food hygiene practices such as washing fruits and vegetables thoroughly and cooking food properly.
  • If experiencing diarrhoea and vomiting, refrain from preparing food for others and avoiding visits to hospitals or care homes to avoid passing on the infection
  • Wait 48 hours after your symptoms have ceased before returning to work, school, or nursery.

Call NHS 111 or contact your GP surgery if you or your child have diarrhoea for more than seven days or vomiting for more than two days.

 

 

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less